Neurovascular Devices / Interventional Neurology

Neurovascular Devices / Interventional Neurology

Global Neurovascular Devices / Interventional Neurology Market to Reach $4.3 Billion by 2027

In the changed post COVID-19 business landscape, the global market for Neurovascular Devices / Interventional Neurology estimated at US$2.6 Billion in the year 2020, is projected to reach a revised size of US$4.3 Billion by 2027, growing at a CAGR of 7.2% over the analysis period 2020-2027. Aneurysm Coiling & Embolization Devices, one of the segments analyzed in the report, is projected to record a 8.1% CAGR and reach US$1.9 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Neurothrombectomy Devices segment is readjusted to a revised 6.5% CAGR for the next 7-year period.

The U.S. Market is Estimated at $779.4 Million, While China is Forecast to Grow at 6.7% CAGR

The Neurovascular Devices / Interventional Neurology market in the U.S. is estimated at US$779.4 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$749.1 Million by the year 2027 trailing a CAGR of 6.7% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 6.8% and 5.7% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 5.8% CAGR.

Cerebral Balloon Angioplasty & Stenting Systems Segment to Record 7.4% CAGR

In the global Cerebral Balloon Angioplasty & Stenting Systems segment, USA, Canada, Japan, China and Europe will drive the 7.4% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$424.2 Million in the year 2020 will reach a projected size of US$701.5 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets.

Select Competitors (Total 12 Featured) -

  • Abbott Laboratories
  • Boston Scientific Corporation
  • Johnson & Johnson
  • Medtronic PLC
  • Merit Medical Systems, Inc.
  • MicroPort Scientific Corporation
  • Penumbra, Inc.
  • Stryker Corporation
  • Terumo Corporation
  • W.L. Gore & Associates, Inc.
Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.


I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Neurovascular Devices/Interventional Neurology – Global Key Competitors Percentage Market Share in 2022 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Recent Past, Current & Future Analysis for Ischemic Strokes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
TABLE 2: World Historic Review for Ischemic Strokes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 3: World 15-Year Perspective for Ischemic Strokes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
TABLE 4: World Recent Past, Current & Future Analysis for Cerebral Aneurysms by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
TABLE 5: World Historic Review for Cerebral Aneurysms by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 6: World 15-Year Perspective for Cerebral Aneurysms by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
TABLE 7: World Neurovascular Devices / Interventional Neurology Market Analysis of Annual Sales in US$ Million for Years 2012 through 2027
TABLE 8: World Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
TABLE 9: World Historic Review for Neurovascular Devices / Interventional Neurology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 10: World 15-Year Perspective for Neurovascular Devices / Interventional Neurology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2021 & 2027
TABLE 11: World Recent Past, Current & Future Analysis for Aneurysm Coiling & Embolization Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
TABLE 12: World Historic Review for Aneurysm Coiling & Embolization Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 13: World 15-Year Perspective for Aneurysm Coiling & Embolization Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
TABLE 14: World Recent Past, Current & Future Analysis for Neurothrombectomy Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
TABLE 15: World Historic Review for Neurothrombectomy Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 16: World 15-Year Perspective for Neurothrombectomy Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
TABLE 17: World Recent Past, Current & Future Analysis for Cerebral Balloon Angioplasty & Stenting Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
TABLE 18: World Historic Review for Cerebral Balloon Angioplasty & Stenting Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 19: World 15-Year Perspective for Cerebral Balloon Angioplasty & Stenting Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
TABLE 20: World Recent Past, Current & Future Analysis for Support Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
TABLE 21: World Historic Review for Support Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 22: World 15-Year Perspective for Support Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
TABLE 23: World Recent Past, Current & Future Analysis for Arteriovenous Malformation & Fistulas by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
TABLE 24: World Historic Review for Arteriovenous Malformation & Fistulas by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 25: World 15-Year Perspective for Arteriovenous Malformation & Fistulas by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
TABLE 26: World Recent Past, Current & Future Analysis for Other Disease Pathologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
TABLE 27: World Historic Review for Other Disease Pathologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 28: World 15-Year Perspective for Other Disease Pathologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
TABLE 29: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
TABLE 30: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 31: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
TABLE 32: World Recent Past, Current & Future Analysis for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
TABLE 33: World Historic Review for Ambulatory Surgery Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 34: World 15-Year Perspective for Ambulatory Surgery Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
TABLE 35: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
TABLE 36: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 37: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2021 & 2027
III. MARKET ANALYSIS
UNITED STATES
Neurovascular Devices / Interventional Neurology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2022 (E)
TABLE 38: USA Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by Disease Pathology - Cerebral Aneurysms, Ischemic Strokes, Arteriovenous Malformation & Fistulas and Other Disease Pathologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 39: USA Historic Review for Neurovascular Devices / Interventional Neurology by Disease Pathology - Cerebral Aneurysms, Ischemic Strokes, Arteriovenous Malformation & Fistulas and Other Disease Pathologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 40: USA 15-Year Perspective for Neurovascular Devices / Interventional Neurology by Disease Pathology - Percentage Breakdown of Value Sales for Cerebral Aneurysms, Ischemic Strokes, Arteriovenous Malformation & Fistulas and Other Disease Pathologies for the Years 2012, 2021 & 2027
TABLE 41: USA Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by Product Type - Aneurysm Coiling & Embolization Devices, Neurothrombectomy Devices, Cerebral Balloon Angioplasty & Stenting Systems and Support Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 42: USA Historic Review for Neurovascular Devices / Interventional Neurology by Product Type - Aneurysm Coiling & Embolization Devices, Neurothrombectomy Devices, Cerebral Balloon Angioplasty & Stenting Systems and Support Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 43: USA 15-Year Perspective for Neurovascular Devices / Interventional Neurology by Product Type - Percentage Breakdown of Value Sales for Aneurysm Coiling & Embolization Devices, Neurothrombectomy Devices, Cerebral Balloon Angioplasty & Stenting Systems and Support Devices for the Years 2012, 2021 & 2027
TABLE 44: USA Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 45: USA Historic Review for Neurovascular Devices / Interventional Neurology by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 46: USA 15-Year Perspective for Neurovascular Devices / Interventional Neurology by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2012, 2021 & 2027
CANADA
TABLE 47: Canada Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by Disease Pathology - Cerebral Aneurysms, Ischemic Strokes, Arteriovenous Malformation & Fistulas and Other Disease Pathologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 48: Canada Historic Review for Neurovascular Devices / Interventional Neurology by Disease Pathology - Cerebral Aneurysms, Ischemic Strokes, Arteriovenous Malformation & Fistulas and Other Disease Pathologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 49: Canada 15-Year Perspective for Neurovascular Devices / Interventional Neurology by Disease Pathology - Percentage Breakdown of Value Sales for Cerebral Aneurysms, Ischemic Strokes, Arteriovenous Malformation & Fistulas and Other Disease Pathologies for the Years 2012, 2021 & 2027
TABLE 50: Canada Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by Product Type - Aneurysm Coiling & Embolization Devices, Neurothrombectomy Devices, Cerebral Balloon Angioplasty & Stenting Systems and Support Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 51: Canada Historic Review for Neurovascular Devices / Interventional Neurology by Product Type - Aneurysm Coiling & Embolization Devices, Neurothrombectomy Devices, Cerebral Balloon Angioplasty & Stenting Systems and Support Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 52: Canada 15-Year Perspective for Neurovascular Devices / Interventional Neurology by Product Type - Percentage Breakdown of Value Sales for Aneurysm Coiling & Embolization Devices, Neurothrombectomy Devices, Cerebral Balloon Angioplasty & Stenting Systems and Support Devices for the Years 2012, 2021 & 2027
TABLE 53: Canada Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 54: Canada Historic Review for Neurovascular Devices / Interventional Neurology by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 55: Canada 15-Year Perspective for Neurovascular Devices / Interventional Neurology by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2012, 2021 & 2027
JAPAN
Neurovascular Devices / Interventional Neurology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2022 (E)
TABLE 56: Japan Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by Disease Pathology - Cerebral Aneurysms, Ischemic Strokes, Arteriovenous Malformation & Fistulas and Other Disease Pathologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 57: Japan Historic Review for Neurovascular Devices / Interventional Neurology by Disease Pathology - Cerebral Aneurysms, Ischemic Strokes, Arteriovenous Malformation & Fistulas and Other Disease Pathologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 58: Japan 15-Year Perspective for Neurovascular Devices / Interventional Neurology by Disease Pathology - Percentage Breakdown of Value Sales for Cerebral Aneurysms, Ischemic Strokes, Arteriovenous Malformation & Fistulas and Other Disease Pathologies for the Years 2012, 2021 & 2027
TABLE 59: Japan Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by Product Type - Aneurysm Coiling & Embolization Devices, Neurothrombectomy Devices, Cerebral Balloon Angioplasty & Stenting Systems and Support Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 60: Japan Historic Review for Neurovascular Devices / Interventional Neurology by Product Type - Aneurysm Coiling & Embolization Devices, Neurothrombectomy Devices, Cerebral Balloon Angioplasty & Stenting Systems and Support Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 61: Japan 15-Year Perspective for Neurovascular Devices / Interventional Neurology by Product Type - Percentage Breakdown of Value Sales for Aneurysm Coiling & Embolization Devices, Neurothrombectomy Devices, Cerebral Balloon Angioplasty & Stenting Systems and Support Devices for the Years 2012, 2021 & 2027
TABLE 62: Japan Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 63: Japan Historic Review for Neurovascular Devices / Interventional Neurology by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 64: Japan 15-Year Perspective for Neurovascular Devices / Interventional Neurology by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2012, 2021 & 2027
CHINA
Neurovascular Devices / Interventional Neurology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2022 (E)
TABLE 65: China Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by Disease Pathology - Cerebral Aneurysms, Ischemic Strokes, Arteriovenous Malformation & Fistulas and Other Disease Pathologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 66: China Historic Review for Neurovascular Devices / Interventional Neurology by Disease Pathology - Cerebral Aneurysms, Ischemic Strokes, Arteriovenous Malformation & Fistulas and Other Disease Pathologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 67: China 15-Year Perspective for Neurovascular Devices / Interventional Neurology by Disease Pathology - Percentage Breakdown of Value Sales for Cerebral Aneurysms, Ischemic Strokes, Arteriovenous Malformation & Fistulas and Other Disease Pathologies for the Years 2012, 2021 & 2027
TABLE 68: China Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by Product Type - Aneurysm Coiling & Embolization Devices, Neurothrombectomy Devices, Cerebral Balloon Angioplasty & Stenting Systems and Support Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 69: China Historic Review for Neurovascular Devices / Interventional Neurology by Product Type - Aneurysm Coiling & Embolization Devices, Neurothrombectomy Devices, Cerebral Balloon Angioplasty & Stenting Systems and Support Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 70: China 15-Year Perspective for Neurovascular Devices / Interventional Neurology by Product Type - Percentage Breakdown of Value Sales for Aneurysm Coiling & Embolization Devices, Neurothrombectomy Devices, Cerebral Balloon Angioplasty & Stenting Systems and Support Devices for the Years 2012, 2021 & 2027
TABLE 71: China Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 72: China Historic Review for Neurovascular Devices / Interventional Neurology by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 73: China 15-Year Perspective for Neurovascular Devices / Interventional Neurology by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2012, 2021 & 2027
EUROPE
Neurovascular Devices / Interventional Neurology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2022 (E)
TABLE 74: Europe Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by Disease Pathology - Cerebral Aneurysms, Ischemic Strokes, Arteriovenous Malformation & Fistulas and Other Disease Pathologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 75: Europe Historic Review for Neurovascular Devices / Interventional Neurology by Disease Pathology - Cerebral Aneurysms, Ischemic Strokes, Arteriovenous Malformation & Fistulas and Other Disease Pathologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 76: Europe 15-Year Perspective for Neurovascular Devices / Interventional Neurology by Disease Pathology - Percentage Breakdown of Value Sales for Cerebral Aneurysms, Ischemic Strokes, Arteriovenous Malformation & Fistulas and Other Disease Pathologies for the Years 2012, 2021 & 2027
TABLE 77: Europe Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2020 through 2027 and % CAGR
TABLE 78: Europe Historic Review for Neurovascular Devices / Interventional Neurology by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 79: Europe 15-Year Perspective for Neurovascular Devices / Interventional Neurology by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2021 & 2027
TABLE 80: Europe Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by Product Type - Aneurysm Coiling & Embolization Devices, Neurothrombectomy Devices, Cerebral Balloon Angioplasty & Stenting Systems and Support Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 81: Europe Historic Review for Neurovascular Devices / Interventional Neurology by Product Type - Aneurysm Coiling & Embolization Devices, Neurothrombectomy Devices, Cerebral Balloon Angioplasty & Stenting Systems and Support Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 82: Europe 15-Year Perspective for Neurovascular Devices / Interventional Neurology by Product Type - Percentage Breakdown of Value Sales for Aneurysm Coiling & Embolization Devices, Neurothrombectomy Devices, Cerebral Balloon Angioplasty & Stenting Systems and Support Devices for the Years 2012, 2021 & 2027
TABLE 83: Europe Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 84: Europe Historic Review for Neurovascular Devices / Interventional Neurology by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 85: Europe 15-Year Perspective for Neurovascular Devices / Interventional Neurology by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2012, 2021 & 2027
FRANCE
Neurovascular Devices / Interventional Neurology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2022 (E)
TABLE 86: France Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by Disease Pathology - Cerebral Aneurysms, Ischemic Strokes, Arteriovenous Malformation & Fistulas and Other Disease Pathologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 87: France Historic Review for Neurovascular Devices / Interventional Neurology by Disease Pathology - Cerebral Aneurysms, Ischemic Strokes, Arteriovenous Malformation & Fistulas and Other Disease Pathologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 88: France 15-Year Perspective for Neurovascular Devices / Interventional Neurology by Disease Pathology - Percentage Breakdown of Value Sales for Cerebral Aneurysms, Ischemic Strokes, Arteriovenous Malformation & Fistulas and Other Disease Pathologies for the Years 2012, 2021 & 2027
TABLE 89: France Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by Product Type - Aneurysm Coiling & Embolization Devices, Neurothrombectomy Devices, Cerebral Balloon Angioplasty & Stenting Systems and Support Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 90: France Historic Review for Neurovascular Devices / Interventional Neurology by Product Type - Aneurysm Coiling & Embolization Devices, Neurothrombectomy Devices, Cerebral Balloon Angioplasty & Stenting Systems and Support Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 91: France 15-Year Perspective for Neurovascular Devices / Interventional Neurology by Product Type - Percentage Breakdown of Value Sales for Aneurysm Coiling & Embolization Devices, Neurothrombectomy Devices, Cerebral Balloon Angioplasty & Stenting Systems and Support Devices for the Years 2012, 2021 & 2027
TABLE 92: France Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 93: France Historic Review for Neurovascular Devices / Interventional Neurology by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 94: France 15-Year Perspective for Neurovascular Devices / Interventional Neurology by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2012, 2021 & 2027
GERMANY
Neurovascular Devices / Interventional Neurology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2022 (E)
TABLE 95: Germany Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by Disease Pathology - Cerebral Aneurysms, Ischemic Strokes, Arteriovenous Malformation & Fistulas and Other Disease Pathologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 96: Germany Historic Review for Neurovascular Devices / Interventional Neurology by Disease Pathology - Cerebral Aneurysms, Ischemic Strokes, Arteriovenous Malformation & Fistulas and Other Disease Pathologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 97: Germany 15-Year Perspective for Neurovascular Devices / Interventional Neurology by Disease Pathology - Percentage Breakdown of Value Sales for Cerebral Aneurysms, Ischemic Strokes, Arteriovenous Malformation & Fistulas and Other Disease Pathologies for the Years 2012, 2021 & 2027
TABLE 98: Germany Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by Product Type - Aneurysm Coiling & Embolization Devices, Neurothrombectomy Devices, Cerebral Balloon Angioplasty & Stenting Systems and Support Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 99: Germany Historic Review for Neurovascular Devices / Interventional Neurology by Product Type - Aneurysm Coiling & Embolization Devices, Neurothrombectomy Devices, Cerebral Balloon Angioplasty & Stenting Systems and Support Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 100: Germany 15-Year Perspective for Neurovascular Devices / Interventional Neurology by Product Type - Percentage Breakdown of Value Sales for Aneurysm Coiling & Embolization Devices, Neurothrombectomy Devices, Cerebral Balloon Angioplasty & Stenting Systems and Support Devices for the Years 2012, 2021 & 2027
TABLE 101: Germany Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 102: Germany Historic Review for Neurovascular Devices / Interventional Neurology by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 103: Germany 15-Year Perspective for Neurovascular Devices / Interventional Neurology by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2012, 2021 & 2027
ITALY
TABLE 104: Italy Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by Disease Pathology - Cerebral Aneurysms, Ischemic Strokes, Arteriovenous Malformation & Fistulas and Other Disease Pathologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 105: Italy Historic Review for Neurovascular Devices / Interventional Neurology by Disease Pathology - Cerebral Aneurysms, Ischemic Strokes, Arteriovenous Malformation & Fistulas and Other Disease Pathologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 106: Italy 15-Year Perspective for Neurovascular Devices / Interventional Neurology by Disease Pathology - Percentage Breakdown of Value Sales for Cerebral Aneurysms, Ischemic Strokes, Arteriovenous Malformation & Fistulas and Other Disease Pathologies for the Years 2012, 2021 & 2027
TABLE 107: Italy Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by Product Type - Aneurysm Coiling & Embolization Devices, Neurothrombectomy Devices, Cerebral Balloon Angioplasty & Stenting Systems and Support Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 108: Italy Historic Review for Neurovascular Devices / Interventional Neurology by Product Type - Aneurysm Coiling & Embolization Devices, Neurothrombectomy Devices, Cerebral Balloon Angioplasty & Stenting Systems and Support Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 109: Italy 15-Year Perspective for Neurovascular Devices / Interventional Neurology by Product Type - Percentage Breakdown of Value Sales for Aneurysm Coiling & Embolization Devices, Neurothrombectomy Devices, Cerebral Balloon Angioplasty & Stenting Systems and Support Devices for the Years 2012, 2021 & 2027
TABLE 110: Italy Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 111: Italy Historic Review for Neurovascular Devices / Interventional Neurology by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 112: Italy 15-Year Perspective for Neurovascular Devices / Interventional Neurology by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2012, 2021 & 2027
UNITED KINGDOM
Neurovascular Devices / Interventional Neurology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2022 (E)
TABLE 113: UK Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by Disease Pathology - Cerebral Aneurysms, Ischemic Strokes, Arteriovenous Malformation & Fistulas and Other Disease Pathologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 114: UK Historic Review for Neurovascular Devices / Interventional Neurology by Disease Pathology - Cerebral Aneurysms, Ischemic Strokes, Arteriovenous Malformation & Fistulas and Other Disease Pathologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 115: UK 15-Year Perspective for Neurovascular Devices / Interventional Neurology by Disease Pathology - Percentage Breakdown of Value Sales for Cerebral Aneurysms, Ischemic Strokes, Arteriovenous Malformation & Fistulas and Other Disease Pathologies for the Years 2012, 2021 & 2027
TABLE 116: UK Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by Product Type - Aneurysm Coiling & Embolization Devices, Neurothrombectomy Devices, Cerebral Balloon Angioplasty & Stenting Systems and Support Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 117: UK Historic Review for Neurovascular Devices / Interventional Neurology by Product Type - Aneurysm Coiling & Embolization Devices, Neurothrombectomy Devices, Cerebral Balloon Angioplasty & Stenting Systems and Support Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 118: UK 15-Year Perspective for Neurovascular Devices / Interventional Neurology by Product Type - Percentage Breakdown of Value Sales for Aneurysm Coiling & Embolization Devices, Neurothrombectomy Devices, Cerebral Balloon Angioplasty & Stenting Systems and Support Devices for the Years 2012, 2021 & 2027
TABLE 119: UK Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 120: UK Historic Review for Neurovascular Devices / Interventional Neurology by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 121: UK 15-Year Perspective for Neurovascular Devices / Interventional Neurology by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2012, 2021 & 2027
REST OF EUROPE
TABLE 122: Rest of Europe Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by Disease Pathology - Cerebral Aneurysms, Ischemic Strokes, Arteriovenous Malformation & Fistulas and Other Disease Pathologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 123: Rest of Europe Historic Review for Neurovascular Devices / Interventional Neurology by Disease Pathology - Cerebral Aneurysms, Ischemic Strokes, Arteriovenous Malformation & Fistulas and Other Disease Pathologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 124: Rest of Europe 15-Year Perspective for Neurovascular Devices / Interventional Neurology by Disease Pathology - Percentage Breakdown of Value Sales for Cerebral Aneurysms, Ischemic Strokes, Arteriovenous Malformation & Fistulas and Other Disease Pathologies for the Years 2012, 2021 & 2027
TABLE 125: Rest of Europe Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by Product Type - Aneurysm Coiling & Embolization Devices, Neurothrombectomy Devices, Cerebral Balloon Angioplasty & Stenting Systems and Support Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 126: Rest of Europe Historic Review for Neurovascular Devices / Interventional Neurology by Product Type - Aneurysm Coiling & Embolization Devices, Neurothrombectomy Devices, Cerebral Balloon Angioplasty & Stenting Systems and Support Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 127: Rest of Europe 15-Year Perspective for Neurovascular Devices / Interventional Neurology by Product Type - Percentage Breakdown of Value Sales for Aneurysm Coiling & Embolization Devices, Neurothrombectomy Devices, Cerebral Balloon Angioplasty & Stenting Systems and Support Devices for the Years 2012, 2021 & 2027
TABLE 128: Rest of Europe Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 129: Rest of Europe Historic Review for Neurovascular Devices / Interventional Neurology by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 130: Rest of Europe 15-Year Perspective for Neurovascular Devices / Interventional Neurology by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2012, 2021 & 2027
ASIA-PACIFIC
Neurovascular Devices / Interventional Neurology Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2022 (E)
TABLE 131: Asia-Pacific Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by Disease Pathology - Cerebral Aneurysms, Ischemic Strokes, Arteriovenous Malformation & Fistulas and Other Disease Pathologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 132: Asia-Pacific Historic Review for Neurovascular Devices / Interventional Neurology by Disease Pathology - Cerebral Aneurysms, Ischemic Strokes, Arteriovenous Malformation & Fistulas and Other Disease Pathologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 133: Asia-Pacific 15-Year Perspective for Neurovascular Devices / Interventional Neurology by Disease Pathology - Percentage Breakdown of Value Sales for Cerebral Aneurysms, Ischemic Strokes, Arteriovenous Malformation & Fistulas and Other Disease Pathologies for the Years 2012, 2021 & 2027
TABLE 134: Asia-Pacific Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by Product Type - Aneurysm Coiling & Embolization Devices, Neurothrombectomy Devices, Cerebral Balloon Angioplasty & Stenting Systems and Support Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 135: Asia-Pacific Historic Review for Neurovascular Devices / Interventional Neurology by Product Type - Aneurysm Coiling & Embolization Devices, Neurothrombectomy Devices, Cerebral Balloon Angioplasty & Stenting Systems and Support Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 136: Asia-Pacific 15-Year Perspective for Neurovascular Devices / Interventional Neurology by Product Type - Percentage Breakdown of Value Sales for Aneurysm Coiling & Embolization Devices, Neurothrombectomy Devices, Cerebral Balloon Angioplasty & Stenting Systems and Support Devices for the Years 2012, 2021 & 2027
TABLE 137: Asia-Pacific Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 138: Asia-Pacific Historic Review for Neurovascular Devices / Interventional Neurology by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 139: Asia-Pacific 15-Year Perspective for Neurovascular Devices / Interventional Neurology by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2012, 2021 & 2027
REST OF WORLD
TABLE 140: Rest of World Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by Disease Pathology - Cerebral Aneurysms, Ischemic Strokes, Arteriovenous Malformation & Fistulas and Other Disease Pathologies - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 141: Rest of World Historic Review for Neurovascular Devices / Interventional Neurology by Disease Pathology - Cerebral Aneurysms, Ischemic Strokes, Arteriovenous Malformation & Fistulas and Other Disease Pathologies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 142: Rest of World 15-Year Perspective for Neurovascular Devices / Interventional Neurology by Disease Pathology - Percentage Breakdown of Value Sales for Cerebral Aneurysms, Ischemic Strokes, Arteriovenous Malformation & Fistulas and Other Disease Pathologies for the Years 2012, 2021 & 2027
TABLE 143: Rest of World Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by Product Type - Aneurysm Coiling & Embolization Devices, Neurothrombectomy Devices, Cerebral Balloon Angioplasty & Stenting Systems and Support Devices - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 144: Rest of World Historic Review for Neurovascular Devices / Interventional Neurology by Product Type - Aneurysm Coiling & Embolization Devices, Neurothrombectomy Devices, Cerebral Balloon Angioplasty & Stenting Systems and Support Devices Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 145: Rest of World 15-Year Perspective for Neurovascular Devices / Interventional Neurology by Product Type - Percentage Breakdown of Value Sales for Aneurysm Coiling & Embolization Devices, Neurothrombectomy Devices, Cerebral Balloon Angioplasty & Stenting Systems and Support Devices for the Years 2012, 2021 & 2027
TABLE 146: Rest of World Recent Past, Current & Future Analysis for Neurovascular Devices / Interventional Neurology by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2020 through 2027 and % CAGR
TABLE 147: Rest of World Historic Review for Neurovascular Devices / Interventional Neurology by End-Use - Hospitals, Ambulatory Surgery Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2019 and % CAGR
TABLE 148: Rest of World 15-Year Perspective for Neurovascular Devices / Interventional Neurology by End-Use - Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Other End-Uses for the Years 2012, 2021 & 2027
IV. COMPETITION

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings